Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 5.23 USD 0.77% Market Closed
Market Cap: 482.1m USD

Wall Street
Price Targets

MYGN Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYGN is 7.65 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.

Lowest
Price Target
4.04 USD
23% Downside
Average
Price Target
7.65 USD
46% Upside
Highest
Price Target
18.9 USD
261% Upside
Myriad Genetics Inc Competitors:
Price Targets
PYC
PYC Therapeutics Ltd
189% Upside
BEAM
Beam Therapeutics Inc
149% Upside
ELDN
Eledon Pharmaceuticals Inc
207% Upside
AZT
Arcticzymes Technologies ASA
13% Upside
PHM
Pharma Mar SA
11% Upside
CUV
Clinuvel Pharmaceuticals Ltd
154% Upside
RCKT
Rocket Pharmaceuticals Inc
394% Upside
KRYS
Krystal Biotech Inc
51% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 3 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYGN's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for MYGN is 7.65 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 3 years is 4%.

Back to Top